Nymox Pharmaceutical Corp. Company Profile (NASDAQ:NYMX)

About Nymox Pharmaceutical Corp.

Nymox Pharmaceutical Corp. logoNymox Pharmaceutical Corporation, formerly Corporation Pharmaceutique Nymox, is a biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also has a patent portfolio covering its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the United States and global patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex conducts research and development, and manufacturing for NicAlert and TobacAlert.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NYMX
  • CUSIP:
Key Metrics:
  • Previous Close: $3.23
  • 50 Day Moving Average: $3.15
  • 200 Day Moving Average: $2.81
  • 52-Week Range: $1.62 - $5.79
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $149.05M
  • Outstanding Shares: 46,145,000
  • Beta: 0.72
Profitability:
  • Net Margins: -6,774.20%
  • Return on Assets: -3,038.71%
Debt:
  • Debt-to-Equity Ratio: -0.39%
  • Current Ratio: 0.29%
  • Quick Ratio: 0.27%
Additional Links:
Companies Related to Nymox Pharmaceutical Corp.:

Analyst Ratings

Consensus Ratings for Nymox Pharmaceutical Corp. (NASDAQ:NYMX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Nymox Pharmaceutical Corp. (NASDAQ:NYMX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Nymox Pharmaceutical Corp. (NASDAQ:NYMX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2014Q314($0.02)ViewN/AView Earnings Details
5/15/2014Q114$0.07$0.18 million$0.08 millionViewN/AView Earnings Details
3/14/2014($0.06)($0.04)ViewN/AView Earnings Details
11/13/2013Q3($0.03)ViewN/AView Earnings Details
5/15/2013Q1 2013($0.05)($0.03)$0.78 million$0.18 millionViewN/AView Earnings Details
11/14/2012Q312($0.06)($0.04)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Nymox Pharmaceutical Corp. (NASDAQ:NYMX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Nymox Pharmaceutical Corp. (NASDAQ:NYMX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Nymox Pharmaceutical Corp. (NASDAQ:NYMX)
Insider Ownership Percentage: 54.00%
Institutional Ownership Percentage: 1.43%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/10/2016James George RobinsonDirectorBuy500$2.47$1,235.00View SEC Filing  
8/4/2016James George RobinsonDirectorBuy7,000$3.41$23,870.00View SEC Filing  
7/29/2016James George RobinsonDirectorBuy22,500$3.86$86,850.00View SEC Filing  
7/20/2016James George RobinsonDirectorBuy10,000$3.33$33,300.00View SEC Filing  
7/7/2016James George RobinsonDirectorBuy20,000$3.28$65,600.00View SEC Filing  
6/29/2016James George RobinsonDirectorBuy17,500$3.53$61,775.00View SEC Filing  
6/24/2016James George RobinsonDirectorBuy22,500$2.97$66,825.00View SEC Filing  
5/13/2016James George RobinsonDirectorBuy28,010$2.31$64,703.10View SEC Filing  
5/3/2016James George RobinsonDirectorBuy6,990$2.36$16,496.40View SEC Filing  
4/29/2016James George RobinsonDirectorBuy15,000$2.27$34,050.00View SEC Filing  
4/15/2016James George RobinsonDirectorBuy39,500$2.39$94,405.00View SEC Filing  
4/1/2016James George RobinsonDirectorBuy20,500$2.40$49,200.00View SEC Filing  
3/24/2016James George RobinsonDirectorBuy40,000$2.29$91,600.00View SEC Filing  
1/12/2016James George RobinsonDirectorBuy20,000$2.44$48,800.00View SEC Filing  
1/8/2016James George RobinsonDirectorBuy95,000$2.90$275,500.00View SEC Filing  
12/30/2015James George RobinsonDirectorBuy5,000$3.38$16,900.00View SEC Filing  
12/29/2015James George RobinsonDirectorBuy14,000$3.55$49,700.00View SEC Filing  
12/28/2015James George RobinsonDirectorBuy6,000$3.79$22,740.00View SEC Filing  
12/23/2015James George RobinsonDirectorBuy29,854$3.54$105,683.16View SEC Filing  
12/18/2015James George RobinsonDirectorBuy63,334$3.56$225,469.04View SEC Filing  
12/11/2015James George RobinsonDirectorBuy46,812$3.51$164,310.12View SEC Filing  
12/4/2015James George RobinsonDirectorBuy110,000$3.44$378,400.00View SEC Filing  
9/3/2015James George RobinsonDirectorBuy100,000$2.25$225,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Nymox Pharmaceutical Corp. (NASDAQ:NYMX)
DateHeadline
News IconNymox Pharmaceutical Corporation (NASDAQ:NYMX): Ignore The Shorts - Street Register (NASDAQ:NYMX)
streetregister.com - September 29 at 11:40 AM
News IconStock Turning Lower in Trade: Nymox Pharmaceutical Corporation (NASDAQ:NYMX) - Post News (NASDAQ:NYMX)
www.kentuckypostnews.com - September 14 at 6:40 PM
News Icon$NOK & $NYMX - Nokia Corp (ADR) (NYSE:NOK) & Nymox Pharmaceutical Corporation (NASDAQ:NYMX) News Recap - Money News (NASDAQ:NYMX)
www.newsismoney.com - September 14 at 6:40 PM
News IconIs Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Overbought After Prostate Drug Hype? - Journal Transcript (NASDAQ:NYMX)
www.journaltranscript.com - September 14 at 6:40 PM
investing.com logoU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41% (NASDAQ:NYMX)
www.investing.com - September 14 at 10:48 AM
News IconNasdaq Index Recovery Rally Stalls as Tech Stocks Hang on By a Thread (NASDAQ:NYMX)
www.economiccalendar.com - September 14 at 10:48 AM
rttnews.com logoNymox Pharmaceutical Corp. (NYMX) Is Suring In Early Trade (NASDAQ:NYMX)
www.rttnews.com - September 14 at 10:48 AM
News IconGetting a Closer Look at Shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) - Duncan Research (NASDAQ:NYMX)
www.duncanindependent.com - September 13 at 11:25 AM
live-pr.com logoNow Available: Nymox Pharmaceutical Corporation (NYMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile (NASDAQ:NYMX)
www.live-pr.com - September 2 at 11:22 AM
News IconStock Down in Trading Session: Nymox Pharmaceutical Corporation (NASDAQ:NYMX) - Post News (NASDAQ:NYMX)
www.kentuckypostnews.com - September 1 at 6:29 PM
News IconNymox Pharmaceutical Corporation's (NYMX): Stock on the Move - Hot Stocks Point (NASDAQ:NYMX)
www.hotstockspoint.com - September 1 at 6:29 PM
4-traders.com logoNymox Pharmaceutical : New Phase 3 Long-Term U.S. Results For Prostate Enlargement Drug Fexapotide Show (NASDAQ:NYMX)
www.4-traders.com - August 30 at 9:52 AM
schaeffersresearch.com logoNymox Pharmaceutical Corporation (NYMX) Puts Popular Despite Drug Data (NASDAQ:NYMX)
www.schaeffersresearch.com - August 30 at 9:52 AM
schaeffersresearch.com logoNymox Pharmaceutical Corporation (NYMX) Puts Popular Despite Drug Data - Schaeffers Research (blog) (NASDAQ:NYMX)
www.schaeffersresearch.com - August 29 at 6:22 PM
finance.yahoo.com logoNymox's New Phase 3 Long-Term U.S. Results For Prostate Enlargement Drug Fexapotide Show (NASDAQ:NYMX)
finance.yahoo.com - August 29 at 11:04 AM
News IconNymox Pharmaceutical Corporation (NASDAQ:NYMX): Ignore The Shorts (NASDAQ:NYMX)
streetregister.com - August 27 at 5:56 PM
insidermonkey.com logoNymox Pharmaceutical Corporation (NYMX) Has More Upside Potential, Even After Gains - Insider Monkey (blog) (NASDAQ:NYMX)
www.insidermonkey.com - August 27 at 10:52 AM
News IconYesterday Trading Recap: Nymox Pharmaceutical Corporation's (NYMX) (NASDAQ:NYMX)
myhealthbowl.com - August 26 at 6:20 PM
thestreet.com logoJabbing a Needle in the Overinflated Nymox Prostate Drug Hype (NASDAQ:NYMX)
www.thestreet.com - August 26 at 6:20 PM
baystreet.ca logoNymox Pharmaceutical (NYMX) Leaps on Study Results (NASDAQ:NYMX)
www.baystreet.ca - August 25 at 6:33 PM
News IconAnti-Prostate Cancer Drug Boosts Nymox Pharma (NYMX); Viveve Medical (VIVE) Moves Into Positive Territory (NASDAQ:NYMX)
galaxystocks.com - August 25 at 6:33 PM
News IconNymox Pharmaceutical Corporation (NYMX) Has More Upside Potential, Even After Gains (NASDAQ:NYMX)
feedproxy.google.com - August 25 at 2:51 PM
benzinga.com logo18 Stocks Moving In Thursday's Pre-Market Session - Benzinga (NASDAQ:NYMX)
www.benzinga.com - August 25 at 11:43 AM
News IconNymox Pharma (NYMX) Stock: Skyrocketing on Positive Study Results - Modest Money (press release) (blog) (NASDAQ:NYMX)
www.modestmoney.com - August 25 at 11:43 AM
finance.yahoo.com logoWhy Nymox Pharma (NYMX) Closed the Day Up 83% (NASDAQ:NYMX)
finance.yahoo.com - August 25 at 11:43 AM
streetinsider.com logoNymox Pharma (NYMX) Announces Successful, Long-Term Fexapotide Phase 3 Data in Prostate Cancer (NASDAQ:NYMX)
www.streetinsider.com - August 24 at 6:20 PM
News IconInvestor News: Nymox Pharmaceutical Corporation (NASDAQ:NYMX) faces Investigation over potential Violations of Securities Laws (NASDAQ:NYMX)
www.groundreport.com - August 24 at 6:20 PM
News IconNymox Pharma (NYMX) Stock: Skyrocketing on Positive Study Results (NASDAQ:NYMX)
www.modestmoney.com - August 24 at 6:20 PM
finance.yahoo.com logo12:19 pm Nymox Pharma announces results from the long-term blinded placebo crossover group from the U.S. Phase 3 trials for fexapotide (NASDAQ:NYMX)
finance.yahoo.com - August 24 at 6:20 PM
finance.yahoo.com logoNymox Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results: Major Reduction in Incidence of Surgery (NASDAQ:NYMX)
finance.yahoo.com - August 24 at 6:20 PM
thestreet.com logoNymox Pharmaceuticals (NYMX) Stock Surges on Long-Term Prostate Drug Trial Success (NASDAQ:NYMX)
www.thestreet.com - August 24 at 6:20 PM
sg.finance.yahoo.com logoNymox reports 2Q loss (NASDAQ:NYMX)
sg.finance.yahoo.com - August 22 at 11:08 AM
News IconHC Stocks Indications: CVS Health Corp (NYSE:CVS), Nymox ... - share market updates (press release) (NASDAQ:NYMX)
sharemarketupdates.com - August 20 at 6:14 PM
streetinsider.com logoNymox Pharma (NYMX) Closes $2.24M Worth of Common Stock Private Placements - StreetInsider.com (NASDAQ:NYMX)
www.streetinsider.com - August 18 at 9:39 AM
News IconNymox Pharmaceutical Corporation's (NYMX): Stock's Financial Statistics - Hot Stocks Point (NASDAQ:NYMX)
www.hotstockspoint.com - August 18 at 9:39 AM
streetinsider.com logoNymox Pharma (NYMX) Closes $2.24M Worth of Common Stock Private Placements (NASDAQ:NYMX)
www.streetinsider.com - August 17 at 6:51 PM
sbwire.com logoNymox Pharmaceutical Corporation (NASDAQ:NYMX) Under Investigation for Investors (NASDAQ:NYMX)
www.sbwire.com - August 17 at 6:51 PM
4-traders.com logoNymox Pharmaceutical : Announces Prostate Drug Progress (NASDAQ:NYMX)
www.4-traders.com - August 17 at 6:51 PM
publicnow.com logoNymox Announces Private Placements of $2.24 Million (NASDAQ:NYMX)
www.publicnow.com - August 17 at 6:51 PM
News IconHealthcare Stock Round up: Nymox Pharmaceutical Corporation's (NYMX) - Hot Stocks Point (NASDAQ:NYMX)
www.hotstockspoint.com - August 15 at 6:54 PM
prnewswire.com logoNymox Pharmaceutical Corporation Investigated For Securities Fraud By Block & Leviton After Report Reveals ... - PR Newswire (press release) (NASDAQ:NYMX)
www.prnewswire.com - August 13 at 9:29 AM
News IconHealthcare Stocks In The News: Kura Oncology Inc (NASDAQ:KURA), Nymox Pharmaceutical Corporation (NASDAQ ... - NYSE Journal (press release) (NASDAQ:NYMX)
stockznews.com - August 12 at 9:47 AM
kcregister.com logoHealthcare Volatile Stocks: Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Kura Oncology, Inc. (NASDAQ ... - KC Register (NASDAQ:NYMX)
www.kcregister.com - August 12 at 9:47 AM
News IconStocks Attracts Frontline Trades- Medtronic (NYSE:MDT), Nymox Pharmaceutical (NASDAQ:NYMX), Radian Group ... - Seneca Globe (NASDAQ:NYMX)
www.senecaglobe.com - August 12 at 9:47 AM
benzinga.com logoIMPORTANT INVESTOR NOTICE: Lundin Law PC... (NASDAQ:NYMX)
www.benzinga.com - August 11 at 7:03 PM
globenewswire.com logoNymox Announces Prostate Drug Progress (NASDAQ:NYMX)
globenewswire.com - August 11 at 7:03 PM
seekingalpha.com logoNymox readies marketing application for BPH drug fexapotide; shares up 31% (NASDAQ:NYMX)
seekingalpha.com - August 11 at 7:03 PM
streetinsider.com logoNymox Pharma (NYMX) Announces Major Fexapotide Development Progress (NASDAQ:NYMX)
www.streetinsider.com - August 11 at 7:03 PM
thestreet.com logoNymox Pharmaceuticals (NYMX) Stock Surges on Prostate Drug Progress (NASDAQ:NYMX)
www.thestreet.com - August 11 at 7:03 PM
News IconNASDAQ Index Near Upper Bollinger Band, At Risk of Turning Downward Eventually (NASDAQ:NYMX)
www.economiccalendar.com - August 11 at 9:48 AM

Social

Nymox Pharmaceutical Corp. (NASDAQ:NYMX) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff